Rohto Pharmaceutical Co.,Ltd. (TYO:4527)

Rohto Pharmaceutical Ratios and Metrics

Market cap in millions JPY. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov 20, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	578,469	505,369	676,888	631,946	421,488	336,849
Market Cap Growth	-24.02%	-25.34%	7.11%	49.93%	25.13%	-0.24%
Enterprise Value	564,386	493,570	610,616	575,682	380,505	296,984
Last Close Price	2560.00	2218.10	2904.20	2690.13	1778.18	1407.26
PE Ratio	16.49	16.30	21.88	23.96	20.05	20.12
Forward PE	17.81	15.19	20.08	24.15	19.94	21.85
PS Ratio	1.73	1.64	2.50	2.65	2.11	1.86
PB Ratio	1.98	1.86	2.74	2.94	2.29	2.15
P/TBV Ratio	2.79	2.48	2.86	3.16	2.49	2.27
P/FCF Ratio	18.25	18.16	25.77	28.15	24.82	29.84
P/OCF Ratio	14.11	13.69	19.77	20.43	15.47	16.84
PEG Ratio	3.56	4.00	4.00	4.00	4.00	4.00
EV/Sales Ratio	1.69	1.60	2.26	2.41	1.91	1.64
EV/EBITDA Ratio	9.89	9.56	12.50	13.93	10.61	10.38
EV/EBIT Ratio	14.01	12.83	15.20	17.17	13.50	13.58
EV/FCF Ratio	17.81	17.73	23.25	25.64	22.41	26.31
Debt / Equity Ratio	0.16	0.19	0.04	0.05	0.12	0.05
Debt / EBITDA Ratio	0.83	0.97	0.21	0.28	0.60	0.28
Debt / FCF Ratio	1.49	1.80	0.40	0.52	1.26	0.72
Asset Turnover	0.79	0.80	0.83	0.82	0.80	0.82
Inventory Turnover	2.34	2.47	2.59	2.72	2.71	2.55
Quick Ratio	1.47	1.55	1.82	1.75	1.74	1.79
Current Ratio	2.17	2.30	2.47	2.37	2.30	2.36
Return on Equity (ROE)	12.90%	11.94%	13.59%	13.25%	12.42%	11.31%
Return on Assets (ROA)	5.90%	6.26%	7.66%	7.17%	7.04%	6.20%
Return on Capital (ROIC)	7.72%	8.30%	10.37%	9.71%	9.53%	8.76%
Return on Capital Employed (ROCE)	11.90%	11.80%	15.50%	14.60%	13.90%	12.90%
Earnings Yield	6.18%	6.13%	4.57%	4.17%	4.99%	4.97%
FCF Yield	5.48%	5.51%	3.88%	3.55%	4.03%	3.35%
Dividend Yield	1.72%	1.62%	0.93%	0.82%	1.01%	1.00%
Payout Ratio	22.86%	22.81%	17.70%	17.73%	16.28%	17.71%
Buyback Yield / Dilution	-0.59%	-0.04%	0.00%	0.00%	-	-0.01%
Total Shareholder Return	1.18%	1.58%	0.93%	0.82%	1.01%	0.99%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.